Beatríz Macías-Murelaga, Gonzaga Garay-Aramburu, Roberto Bergado-Mijangos, Daniel Coello-Ojeda, Itziar Ozaeta, Pio Jésus Garcia-Gómez, Jesús Garrido-Fierro, Manuel Rodríguez-Vallejo, Joaquín Fernández
{"title":"单焦点人工晶状体的预测误差稳定和长期标准结果。","authors":"Beatríz Macías-Murelaga, Gonzaga Garay-Aramburu, Roberto Bergado-Mijangos, Daniel Coello-Ojeda, Itziar Ozaeta, Pio Jésus Garcia-Gómez, Jesús Garrido-Fierro, Manuel Rodríguez-Vallejo, Joaquín Fernández","doi":"10.3390/vision6010005","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study was to assess the stability and differences between objective (O-Rx) and subjective (S-Rx) refraction for the assessment of the prediction error (PE). A secondary aim was to report the results of a monofocal intraocular lens (IOL). 100 subjects were included for whom S-Rx and O-Rx were obtained for all visits, and for visual performance, posterior capsular opacification incidence and Nd:YAG rates at 12 months. Either S-Rx and O-Rx showed a hyperopic shift from 1 to 6 months (<i>p</i> < 0.05) and stabilization after 6 months. S-Rx was related with the axial length (rho = -0.29, <i>p</i> = 0.007), obtaining a major tendency towards hyperopia in short eyes implanted with high-power IOLs. O-Rx showed a myopic shift in comparison to S-Rx (<i>p</i> < 0.05). This resulted in a decrease of the number of eyes in ±0.50 D and ±1.00 D from 79 to 67% and from 94 to 90%, respectively. The median (interquartile range) uncorrected and corrected visual acuities were 0.1 (0.29) and 0 (0.12) logMAR, respectively, and seven eyes required Nd:YAG capsulotomy at 12 months. Some caution should be taken in PE studies in which O-Rx is used or S-Rx is measured in a 1-month follow-up. Constant optimization should be conducted for this IOL after S-Rx stabilization.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788560/pdf/","citationCount":"4","resultStr":"{\"title\":\"Prediction Error Stabilization and Long-Term Standard Results with a Monofocal Intraocular Lens.\",\"authors\":\"Beatríz Macías-Murelaga, Gonzaga Garay-Aramburu, Roberto Bergado-Mijangos, Daniel Coello-Ojeda, Itziar Ozaeta, Pio Jésus Garcia-Gómez, Jesús Garrido-Fierro, Manuel Rodríguez-Vallejo, Joaquín Fernández\",\"doi\":\"10.3390/vision6010005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The aim of this study was to assess the stability and differences between objective (O-Rx) and subjective (S-Rx) refraction for the assessment of the prediction error (PE). A secondary aim was to report the results of a monofocal intraocular lens (IOL). 100 subjects were included for whom S-Rx and O-Rx were obtained for all visits, and for visual performance, posterior capsular opacification incidence and Nd:YAG rates at 12 months. Either S-Rx and O-Rx showed a hyperopic shift from 1 to 6 months (<i>p</i> < 0.05) and stabilization after 6 months. S-Rx was related with the axial length (rho = -0.29, <i>p</i> = 0.007), obtaining a major tendency towards hyperopia in short eyes implanted with high-power IOLs. O-Rx showed a myopic shift in comparison to S-Rx (<i>p</i> < 0.05). This resulted in a decrease of the number of eyes in ±0.50 D and ±1.00 D from 79 to 67% and from 94 to 90%, respectively. The median (interquartile range) uncorrected and corrected visual acuities were 0.1 (0.29) and 0 (0.12) logMAR, respectively, and seven eyes required Nd:YAG capsulotomy at 12 months. Some caution should be taken in PE studies in which O-Rx is used or S-Rx is measured in a 1-month follow-up. Constant optimization should be conducted for this IOL after S-Rx stabilization.</p>\",\"PeriodicalId\":36586,\"journal\":{\"name\":\"Vision (Switzerland)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788560/pdf/\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vision (Switzerland)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/vision6010005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vision (Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/vision6010005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Prediction Error Stabilization and Long-Term Standard Results with a Monofocal Intraocular Lens.
The aim of this study was to assess the stability and differences between objective (O-Rx) and subjective (S-Rx) refraction for the assessment of the prediction error (PE). A secondary aim was to report the results of a monofocal intraocular lens (IOL). 100 subjects were included for whom S-Rx and O-Rx were obtained for all visits, and for visual performance, posterior capsular opacification incidence and Nd:YAG rates at 12 months. Either S-Rx and O-Rx showed a hyperopic shift from 1 to 6 months (p < 0.05) and stabilization after 6 months. S-Rx was related with the axial length (rho = -0.29, p = 0.007), obtaining a major tendency towards hyperopia in short eyes implanted with high-power IOLs. O-Rx showed a myopic shift in comparison to S-Rx (p < 0.05). This resulted in a decrease of the number of eyes in ±0.50 D and ±1.00 D from 79 to 67% and from 94 to 90%, respectively. The median (interquartile range) uncorrected and corrected visual acuities were 0.1 (0.29) and 0 (0.12) logMAR, respectively, and seven eyes required Nd:YAG capsulotomy at 12 months. Some caution should be taken in PE studies in which O-Rx is used or S-Rx is measured in a 1-month follow-up. Constant optimization should be conducted for this IOL after S-Rx stabilization.